NEWSROOM
Discover all the actions carried out by Jeito and all the partnerships that we set up day after day for the well-being of patients and medical progress.
In the headlines
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion
This acquisition reflects the significant clinical progress achieved with Restoret™,EyeBio’s novel late-phase candidate for diabetic macular edema,as well as a preclinical pipeline targeting retinal diseases - Restoret anticipated to enter pivotal study for diabetic...
Find all our press releases
Jeito Capital announces appointment of new Partner Investor Ksenija Pavletic
Paris, France, 3 January 2024 - Jeito Capital ("Jeito"), a global leading independent private...
Jeito Capital creates a community of leading international Special Advisors to complement its extensive sets of skills and further extend its support to portfolio companies
Paris, France, November 29th 2023 - Jeito Capital (“Jeito”), a leading global investment company...
Jeito Capital leads €75 million Series B Financing in NMD Pharma, a Danish company, to develop breakthrough treatments for patients with severe neuromuscular diseases
Jeito Capital’s second round of funding will support NMD Pharma in becoming a leading, global,...
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
EyeBio doubles the size of its original Series A raise with an additional $65 million, with new...
Jeito Capital renewed in “TIBI 2”
Paris, France, September 11th 2023 - Three years after being the 1st biopharma fund to be awarded...
Jeito Capital co-leads EUR 65 million (USD 71 million) financing in Corteria Pharmaceuticals, a French biopharmaceutical company developing novel treatments for cardiovascular diseases
Jeito Capital co-leads oversubscribed financing Corteria, a late preclinical stage company, is...
Face to face
Meet Jeito
9-11
September
All day long
IPEM Paris 2024
Jeito will be present at IPEM, the International Private Equity Market, an international forum bringing together the major players in Private Equity, in Paris, France.
25-26
September
All day long
Invest Europe – Venture Capital Forum 2024
Jeito will be present at the Venture Capital Forum 2024 of Invest Europe, a leading European conference for LPs and GPs engaged in VC activity, in Amsterdam, Netherlands. Dr Rafaèle Tordjman, Founder & CEO of Jeito Capital, will be sharing her views as a speaker on the conference “Maximising Exit Strategies” on the 26th of September from 4pm to 4.45pm.